Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check25 days agoChange DetectedA notice about NIH terminology changes appears on the page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision metadata on the page was updated from v3.6.6 to v3.7.0. This represents a page release or backend/UI update and does not modify study data or visible content.SummaryDifference0.0%

- Check74 days agoChange DetectedVersion label updated to v3.6.6, replacing the previous v3.6.5; this reflects a newer page revision rather than any content change.SummaryDifference0.0%

- Check95 days agoChange DetectedA new version entry is added on 2026-08-07 showing Study Status and Revision: v3.6.5, updating the record history. The earlier entry for v3.6.4 dated 2026-04-13 is removed.SummaryDifference0.1%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.